cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Senti Biosciences Inc
5 own
2 watching
Current Price
$5.67
$-0.53
(-8.63%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
12.13M
52-Week High
52-Week High
16.94000
52-Week Low
52-Week Low
1.52000
Average Volume
Average Volume
0.39M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization12.13M
icon52-Week High16.94000
icon52-Week Low1.52000
iconAverage Volume0.39M
iconDividend Yield--
iconP/E Ratio--
What does the Senti Biosciences Inc do?
Senti Biosciences, Inc. is a clinical-stage biotechnology company. It is developing cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. It is focused on off-the-shelf CAR-NK cell therapy programs for oncology indications. Its lead product candidate, SENTI-202, is a potential Logic Gated off-the-shelf CAR-NK cell therapy designed to selectively target and eliminate CD33 and/or FLT3 expressing hematologic malignancies, including acute myeloid leukemia, while sparing healthy bone marrow cells. Its second clinical development program is SENTI-301A, a multi-armed off-the-shelf healthy donor derived CAR-NK cell therapy. SENTI-202 has been designed to incorporate three chimeric proteins using a Logic Gated gene circuit and delivered through a single retrovirus. SENTI-301A is a multi-armed off-the-shelf healthy donor derived CAR-NK cell therapy designed for the treatment of advanced GPC3 positive tumors.
Read More
News & Events about Senti Biosciences Inc.
Globe Newswire
1 year ago
NEWTOWN, Pa., June 28, 2023 (GLOBE NEWSWIRE) -- The law firm of Edelson Lechtzin LLP is investigating securities fraud and breach of fiduciary duty claims on behalf of shareholders of Dynamics...
Globe Newswire
1 year ago
SAN DIEGO, June 24, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of law in connection with the following special purpose acquisition companies ("SPACs"): Pardes Biosciences, Inc. f/k/a FS Development Corp. II (NASDAQ: PRDS) Gemini ...
Globe Newswire
1 year ago
SAN DIEGO, June 12, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of law in connection with the following special purpose acquisition companies ("SPACs") and whether investors' losses may be recovered under the federal securities laws...
Globe Newswire
1 year ago
SAN DIEGO, May 02, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of law in connection with the following special purpose acquisition companies ("SPACs") and whether investors' losses may be recovered under the federal securities laws. ...
Globe Newswire
1 year ago
Preclinical data supports SENTI-202 as a potential first-in-class logic gated CAR-NK cell therapy; remains on track for IND submission in 2H 2023 Additional data presented on SENTI-301A and crIL-15 support Sentis development of gene circuit enhanced CAR-NK programs for multiple cancer indications ...
Frequently Asked Questions
Frequently Asked Questions
What is Senti Biosciences Inc share price today?
plus_minus_icon
Can Indians buy Senti Biosciences Inc shares?
plus_minus_icon
How can I buy Senti Biosciences Inc shares from India?
plus_minus_icon
Can Fractional shares of Senti Biosciences Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Senti Biosciences Inc stocks?
plus_minus_icon
What is today’s traded volume of Senti Biosciences Inc?
plus_minus_icon
What is today’s market capitalisation of Senti Biosciences Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Senti Biosciences Inc?
plus_minus_icon
What percentage is Senti Biosciences Inc down from its 52-Week High?
plus_minus_icon
What percentage is Senti Biosciences Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$5.67
$-0.53
(-8.63%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00